Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: On drug treatment and social control: Russian narcology's great leap backwards | Harm Reduction Journal BioMed Central Editorial Open Access On drug treatment and social control Russian narcology s great leap backwards Richard Elovich 1 and Ernest Drucker1 2 Address 1Columbia University Mailman School of Public Health NYC USA and 2Montefiore Medical Center Albert Einstein College of Medicine NYC USA Email Richard Elovich - elovichnyc@yahoo.com Ernest Drucker - emdrucker@earthlink.net Corresponding author Published 24 June 2008 Received 21 January 2008 Harm Reduction Journal 2008 5 23 doi 10.1186 1477-7517-5-23 Accepted 24 June 2008 This article is available from http www.harmreductionjournal.cOm content 5 1 23 2008 Elovich and Drucker licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract__ The medical discipline of narcology in Russia is a subspecialty of psychiatry from the Soviet era and it is given warrant to define the scope of health activities with regard to alcohol and other drug use drug users and related problems. Narcological practice is in turn constrained by the State. The emergence of widespread injection opiate use and associated HIV morbidities and mortalities during the first decade following the collapse of the Soviet Union has brought the contradictions in Russian narcological discourse into high relief. Narcology officials in the Russian Federation have consistently opposed substitution treatment for opiate dependence - the replacement of a shortacting illegal substance with a longer acting prescribed drug with similar pharmacological action but lower degree of risk. Thus despite the addition of methadone and buprenorphine to WHO s list of essential medicines in 2005 and multiple position papers by .
